Evaluation of the Physical Compatibility of Intravenous Methocarbamol in Lactated Ringer's, 0.45% Normal Saline, and Plasma-Lyte A.

IF 0.7 Q4 PHARMACOLOGY & PHARMACY Hospital Pharmacy Pub Date : 2025-02-01 Epub Date: 2024-09-12 DOI:10.1177/00185787241279375
Aaron T Twardzik, Justin P Reinert, Gabriella Baki, Mariann D Churchwell, Mitchell S Howard
{"title":"Evaluation of the Physical Compatibility of Intravenous Methocarbamol in Lactated Ringer's, 0.45% Normal Saline, and Plasma-Lyte A.","authors":"Aaron T Twardzik, Justin P Reinert, Gabriella Baki, Mariann D Churchwell, Mitchell S Howard","doi":"10.1177/00185787241279375","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The need to determine physical compatibility of intravenous admixtures is directly related to patient safety and patient outcomes. While the provision of multi-modal analgesic strategies has increased over the past decade, a paucity of data exists regarding physical compatibility of select medications. <b>Objectives:</b> To evaluate the physical compatibility of methocarbamol in Lactated Ringer's (LR), 0.45% normal saline (0.45% NaCl), and Plasma-Lyte A (PLA) at concentrations of 4, 10, and 20 mg/mL. <b>Methods:</b> Admixtures were prepared and evaluated using previously validated methods under a laminar flow hood using aseptic technique. Samples were prepared in a triplicate manner, 3 mL aliquots were placed into polymethyl methacrylate cuvettes for evaluation at time points 0, 1, 5, 8, and 24 hours. Visual inspection of samples included assignment of a number: 0-no precipitation, 1-trace evidence of precipitation, 2-slight haze, 3-medium haze, and 4-heavy precipitation. Any evidence of precipitation was considered significant. A variable wavelength spectrophotometer set at 547 nanometers was used to measure absorbance. A change in absorbance of ±0.010 was considered significant. A change in pH of ±0.1 was considered significant. <b>Results:</b> No significant changes occurred relating to visual inspection or absorbance across all concentrations and time points for LR; however, there was a significant change in pH across all concentrations at hour 5. In 0.45% NaCl and PLA, no remarkable changes occurred across all concentrations and time points regarding visual observation, spectrophotometric absorbance, and pH analysis. <b>Conclusions:</b> Methocarbamol at concentrations of 4, 10, and 20 mg/mL is physically compatible for up to 1 hour in LR. Methocarbamol is physically compatible in 0.45% NaCl and PLA for up to 24 hours. Chemical stability tests are warranted to confirm these findings.</p>","PeriodicalId":13002,"journal":{"name":"Hospital Pharmacy","volume":" ","pages":"60-65"},"PeriodicalIF":0.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/00185787241279375","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The need to determine physical compatibility of intravenous admixtures is directly related to patient safety and patient outcomes. While the provision of multi-modal analgesic strategies has increased over the past decade, a paucity of data exists regarding physical compatibility of select medications. Objectives: To evaluate the physical compatibility of methocarbamol in Lactated Ringer's (LR), 0.45% normal saline (0.45% NaCl), and Plasma-Lyte A (PLA) at concentrations of 4, 10, and 20 mg/mL. Methods: Admixtures were prepared and evaluated using previously validated methods under a laminar flow hood using aseptic technique. Samples were prepared in a triplicate manner, 3 mL aliquots were placed into polymethyl methacrylate cuvettes for evaluation at time points 0, 1, 5, 8, and 24 hours. Visual inspection of samples included assignment of a number: 0-no precipitation, 1-trace evidence of precipitation, 2-slight haze, 3-medium haze, and 4-heavy precipitation. Any evidence of precipitation was considered significant. A variable wavelength spectrophotometer set at 547 nanometers was used to measure absorbance. A change in absorbance of ±0.010 was considered significant. A change in pH of ±0.1 was considered significant. Results: No significant changes occurred relating to visual inspection or absorbance across all concentrations and time points for LR; however, there was a significant change in pH across all concentrations at hour 5. In 0.45% NaCl and PLA, no remarkable changes occurred across all concentrations and time points regarding visual observation, spectrophotometric absorbance, and pH analysis. Conclusions: Methocarbamol at concentrations of 4, 10, and 20 mg/mL is physically compatible for up to 1 hour in LR. Methocarbamol is physically compatible in 0.45% NaCl and PLA for up to 24 hours. Chemical stability tests are warranted to confirm these findings.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在乳酸林格氏液、0.45% 生理盐水和血浆-Lyte A 中静脉注射甲氧卡因的物理相容性评估
背景:确定静脉注射混合物的物理兼容性直接关系到患者的安全和治疗效果。在过去十年中,虽然提供多模式镇痛策略的情况有所增加,但有关特定药物物理兼容性的数据却很少。目的:评估甲氧苄啶的物理兼容性:评估乳酸林格液(LR)、0.45% 正常生理盐水(0.45% NaCl)和血浆-莱特 A(PLA)中浓度为 4、10 和 20 毫克/毫升的甲氧卡松的物理相容性。方法:在层流罩内采用无菌技术,使用先前验证过的方法制备和评估混合物。以一式三份的方式制备样品,将 3 毫升等分样品放入聚甲基丙烯酸甲酯比色皿中,在 0、1、5、8 和 24 小时的时间点进行评估。对样品的目测包括编号:0-无沉淀、1-有微量沉淀、2-轻度混浊、3-中度混浊和 4-大量沉淀。任何降水迹象都被视为重要降水。使用设置在 547 纳米的可变波长分光光度计测量吸光度。吸光度变化在 ±0.010 范围内视为显著变化。pH 值的±0.1 变化被视为显著变化。结果:在所有浓度和时间点上,LR 的肉眼观察和吸光度均未发生明显变化;但在第 5 小时,所有浓度的 pH 值均发生了明显变化。 在 0.45% NaCl 和 PLA 中,所有浓度和时间点上的肉眼观察、分光光度计吸光度和 pH 值分析均未发生明显变化。结论浓度为 4、10 和 20 毫克/毫升的美索卡莫尔在 LR 中的物理相容性可达 1 小时。在 0.45% 氯化钠和聚乳酸中,甲氧卡巴摩尔的物理相容性可达 24 小时。需要进行化学稳定性测试来证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hospital Pharmacy
Hospital Pharmacy PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
0.00%
发文量
63
期刊介绍: Hospital Pharmacy is a monthly peer-reviewed journal that is read by pharmacists and other providers practicing in the inpatient and outpatient setting within hospitals, long-term care facilities, home care, and other health-system settings The Hospital Pharmacy Assistant Editor, Michael R. Cohen, RPh, MS, DSc, FASHP, is author of a Medication Error Report Analysis and founder of The Institute for Safe Medication Practices (ISMP), a nonprofit organization that provides education about adverse drug events and their prevention.
期刊最新文献
Practice and Determinants of Spontaneous Adverse Drug Reaction Reporting Among Healthcare Professionals: A Multicenter Cross-Sectional Study in Vietnam. Reliability and Feasibility Assessment of EldenCare: A Geriatric Clinical Decision Support System Pilot Study. Evaluation of the Safety and Effectiveness of Two Nomograms for the Management of Diabetic Ketoacidosis. Characterization of Electronic Missing Medication Requests to Identify Medication-Use System Vulnerabilities and Interprofessional Workflow Targets. Physicochemical Stability of the Rituximab Biosimilar ABP 798 in Intravenous Bags Following Preparation and Storage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1